ID: ALA4641806

Max Phase: Preclinical

Molecular Formula: C37H47Br2N9O5

Molecular Weight: 857.65

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N(C(N)=O)c2ccccc2)CC1)C(=O)N1CCN(c2ccncc2)CC1

Standard InChI:  InChI=1S/C37H47Br2N9O5/c38-29-22-25(23-30(39)33(29)49)24-32(44-37(53)47-16-11-28(12-17-47)48(36(41)52)27-6-2-1-3-7-27)34(50)43-31(8-4-5-13-40)35(51)46-20-18-45(19-21-46)26-9-14-42-15-10-26/h1-3,6-7,9-10,14-15,22-23,28,31-32,49H,4-5,8,11-13,16-21,24,40H2,(H2,41,52)(H,43,50)(H,44,53)/t31-,32+/m0/s1

Standard InChI Key:  TYOGCTPXYBIGHG-AJQTZOPKSA-N

Associated Targets(Human)

Calcitonin-gene-related peptide receptor, CALCRL/RAMP1 193 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 857.65Molecular Weight (Monoisotopic): 855.2067AlogP: 3.95#Rotatable Bonds: 13
Polar Surface Area: 190.46Molecular Species: BASEHBA: 8HBD: 5
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 6.75CX Basic pKa: 10.20CX LogP: 1.29CX LogD: 0.54
Aromatic Rings: 3Heavy Atoms: 53QED Weighted: 0.16Np Likeness Score: -0.78

References

1. Dubowchik GM, Conway CM, Xin AW..  (2020)  Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success.,  63  (13): [PMID:32058712] [10.1021/acs.jmedchem.9b01810]

Source